healio.com
Stelara, Entyvio have ‘comparable’ cardiovascular safety profiles in older adults with IBD
Cure8 flagged this item because the article title and available source metadata connect it to Inflammatory bowel disease, Crohn's disease, Ulcerative colitis, and Ustekinumab. We do not yet have enough reliable article text to summarize the details.
This may be most useful for Clinicians, Adult patients, and Patients On Biologics following Inflammatory bowel disease, Crohn's disease, Ulcerative colitis, Ustekinumab, and Vedolizumab.
What To Know
Cure8 does not have enough reliable source text to summarize this article yet. Based on the article title and source metadata, this appears to be a conference abstract related to Inflammatory bowel disease, Crohn's disease, Ulcerative colitis, and Ustekinumab. Use the original source link for the full details.
The original article from healio.com has the full details, including any study limitations or source context.
